PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-6.10%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-6.10%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.10%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-6.10%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
6.10%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.61%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.61%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.